Get the Stockscreener App
1.84
2.63%
-0.06
Tff Pharmaceuticals Inc stock is traded at $1.84, with a volume of 37,404.
It is down -2.63% in the last 24 hours and down -1.07% over the past month.
TFF Pharmaceuticals Inc is a biopharmaceutical company focused on developing and commercializing drug products based on its patented Thin Film Freezing, or TFF, technology platform. It is focused on the development of inhaled dry powder drugs for the treatment of lung disorders.
See More
Previous Close:
$1.90
Open:
$1.84
24h Volume:
37,404
Relative Volume:
0.54
Market Cap:
$6.59M
Revenue:
-
Net Income/Loss:
$-19.93M
P/E Ratio:
-2.5556
EPS:
-0.72
Net Cash Flow:
$-14.82M
1W Performance:
-11.90%
1M Performance:
-1.07%
6M Performance:
-8.87%
1Y Performance:
+534.43%
1-Day Range:
$1.84
$1.8915
1-Week Range:
$1.818
$3.23
52-Week Range:
$0.2058
$11.00
Tff Pharmaceuticals Inc Stock (TFFP) Company Profile
Name
Tff Pharmaceuticals Inc
Sector
Industry
Phone
737-802-1973
Address
2600 VIA FORTUNA, SUITE 360, AUSTIN
Tff Pharmaceuticals Inc Stock (TFFP) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-19-22 | Resumed | H.C. Wainwright | Buy |
| Feb-08-21 | Initiated | H.C. Wainwright | Buy |
| Dec-07-20 | Initiated | B. Riley Securities | Buy |
| Aug-17-20 | Reiterated | Maxim Group | Buy |
| Jul-08-20 | Initiated | Maxim Group | Buy |
Tff Pharmaceuticals Inc Stock (TFFP) Latest News
Pre-market Movers: EVOK, HCTI, GLUE, MNPR... - RTTNews
tff pharmaceuticals, inc. Earnings dates - RTTNews
Asthma Competitive Landscape Report 2024 (Updated) - openPR
Ebola Virus Drug Development Pipeline Expands with Contributions from 18+ Key Companies | DelveInsight - GlobeNewswire
TFF Pharmaceuticals (TFFP) Upgraded to Strong Buy: Here's Why - MSN
Aspergillosis Market to Show Remarkable Growth Trends from 2024 - openPR
ROTH to Host 3rd Annual Healthcare Opportunities Conference on October 9 in New York City - The Manila Times
Inhalable Drugs Market Report Details Expansion, Future Growth Rate, Industry Insights, Top Trends And Fore... - WhaTech
Immunosuppressants Market to Witness Stunning Growth at a CAGR of 7.2% - openPR
Roth/MKM maintains Buy on TFF Pharmaceuticals stock, emphasizes inhalation tech breakthrough - Investing.com Canada
TFF Pharmaceuticals' Technology Generates Superior Inhalational Dry Powder Formulations for Pulmonary Drug Delivery - The Manila Times
TFF Pharmaceuticals’ Technology Generates Superior Inhalational Dry Powder Formulations for Pulmonary Drug Delivery - StockTitan
US law firm merger streak continues with Taft tie-up - Reuters
Taft and Sherman & Howard to combine in latest large US merger - The Global Legal Post
Top Biglaw Firm Announces Merger With Top Midsize Firm - Above the Law
Taft Announces Expansion Into The Mountain West With Sherman & Howard Merger - MENAFN.COM
Insider Selling: TFI International Inc. (TSE:TFII) Director Sells 25,000 Shares of Stock - Defense World
45,000 Shares in Teleflex Incorporated (NYSE:TFX) Purchased by Integral Health Asset Management LLC - MarketBeat
Tube Investments share price down 1.12 per cent - The Economic Times
Westwood Holdings Group Inc. Acquires 31,104 Shares of Teleflex Incorporated (NYSE:TFX) - Defense World
Teleflex Incorporated (NYSE:TFX) Shares Acquired by Hsbc Holdings PLC - Defense World
Public Employees Retirement Association of Colorado Reduces Stock Holdings in Teleflex Incorporated (NYSE:TFX) - Defense World
Acadian Asset Management LLC Increases Stock Holdings in Teleflex Incorporated (NYSE:TFX) - Defense World
Argent Trust Co Buys Shares of 3,939 The Toro Company (NYSE:TTC) - Defense World
Analyst bullish on Tectonic's TX45 ahead of full trial results presentation at AHA - Investing.com India
Argent Trust Co Purchases 102 Shares of Teleflex Incorporated (NYSE:TFX) - Defense World
XTX Topco Ltd Purchases New Holdings in The Toro Company (NYSE:TTC) - Defense World
Tangential Flow Filtration Market Size to Hit USD 7.79 Bn by 2034 - Precedence Research
Teleflex Incorporated (NYSE:TFX) Shares Sold by Citizens Financial Group Inc. RI - Defense World
TECX Stock Hits 52-Week High at $19.68 Amid Market Optimism - Investing.com
Victory Capital Management Inc. Sells 4,770 Shares of Teleflex Incorporated (NYSE:TFX) - Defense World
Massachusetts Financial Services Co. MA Reduces Stock Holdings in Teleflex Incorporated (NYSE:TFX) - MarketBeat
Hidden Gem: Metal stock that ventured into defence sector to manufacture arms and ammunition - Trade Brains
State of New Jersey Common Pension Fund D Sells 8,836 Shares of Teleflex Incorporated (NYSE:TFX) - Defense World
Teleflex Incorporated (NYSE:TFX) Shares Sold by Commonwealth Equity Services LLC - Defense World
Traws Pharma Announces Stock Split, Share Adjustments, and Growth Strategy - TipRanks
Forsta AP Fonden Cuts Holdings in Teleflex Incorporated (NYSE:TFX) - Defense World
DZS Announces CFO Departure, Names Interim CFO - dallasinnovates.com
TFF H1, H3 vaccine candidates produce protective antibodies in ferrets - BioWorld Online
TFF Pharmaceuticals partners with Emory University on antiviral tech - Investing.com
TFF Pharmaceuticals Partners with Emory University and BARDA to Develop a Dry Powder Inhaled mRNA-based Treatment for Influenza and COVID - ForexTV.com
TFF Pharmaceuticals reports progress in universal flu vaccine - Investing.com
Pre-Market Boost For TFF Pharmaceuticals (TFFP) After Encouraging Preclinical Data - Stocks Telegraph
TFF Pharmaceuticals Announces Positive Preclinical Data from Bivalent Universal Influenza Vaccine Candidates Manufactured by TFF Following Intranasal Immunization - ForexTV.com
Nasal Packing Devices: Global Market Forecasts from 2024 to - GlobeNewswire
TFF Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference - StockTitan
How To Buy TFF Pharmaceuticals Inc Stock Online in August 2024 - Traders Union
The Future of Medicine: Drug Delivery Innovations Leading a $700 Billion Market - Baystreet.ca
TFF Pharmaceuticals, Inc. Expected to Post Q3 2024 Earnings of ($0.81) Per Share (NASDAQ:TFFP) - Defense World
TFF Pharmaceuticals (FRA:0K30) Debt-to-Revenue : 0.12 (As of Mar. 2024) - GuruFocus.com
TFF Pharmaceuticals (FRA:0K30) EV-to-Revenue : 17.92 (As of Aug. 18, 2024) - GuruFocus.com
Tff Pharmaceuticals Inc Stock (TFFP) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.75%
0.20%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):